Related Experiment Video
Updated: May 22, 2026

A Melanoma Patient-Derived Xenograft Model
Published on: May 20, 2019
Dramatic regression of amelanotic choroidal melanoma with PDT following poor response to brachytherapy
Samuray Tuncer1, Nur Kir, Carol L Shields
1Istanbul University, Istanbul Faculty of Medicine, Department of Ophthalmology, Istanbul, Turkey. sbtuncer@yahoo.com
Abstract:
Photodynamic therapy (PDT) has been used for treatment of choroidal neovascular membrane from exudative macular degeneration. Other applications include treatment of some intraocular tumors, such as choroidal hemangioma, vasoproliferative tumor, and choroidal osteoma. The authors report the effect of PDT for amelanotic choroidal melanoma. A 40-year-old woman with an amelanotic choroidal melanoma of 6.5 mm thickness showed poor response to iodine brachytherapy (80 Gy apical dose) with no reduction in thickness at 16 months of follow-up. There was prominent residual tumor. The amelanotic tumor was treated with verteporfin PDT using three overlapping spots (8,600 microns), with avoidance of the optic disc using standard treatment parameters. Dramatic tumor regression over 2 months to a completely flat scar (1.3 mm thickness) was documented and remained stable at 50 months of follow-up. Amelanotic choroidal melanoma with incomplete response following conventional plaque radiotherapy can be treated with verteporfin PDT for consolidation.
